Zydus Lifesciences Share Price in Focus After Signing Agreement for Sri Lanka Plant

Zydus Sunshine Lifesciences signed the agreement with Sri Lanka's Board of Investment on October 13. The plant will come up in Horana, where the joint venture plans to manufacture medicines for the local market. 

Plant Construction and Investment Plans 

The project will be spread across nearly four acres, with investment planned in phases. The companies expect the plant to start commercial production in 2028, subject to approvals and the project schedule. 

Tablets and Capsules in the First Phase 

The factory will initially produce oral medicines, including tablets and capsules, for patients in Sri Lanka. The companies expect local manufacturing to help improve the supply of essential medicines. 

Zydus Lifesciences and Sunshine Healthcare announced their joint venture on June 26, 2026. The latest agreement sets out plans for the manufacturing facility in Horana. 

Read More: Leela Palaces Share Price in Focus After Q2 FY27 Earnings Results; Q2 Profit Rises 27%! 

Zydus Lifesciences Share Price Performance 

As of October 15, 2026, at 2:14 PM, Zydus Lifesciences share price was trading at ₹1,146.40 per share, reflecting a 1.93% change from the previous trading session. 

Conclusion 

The proposed plant will give Zydus Sunshine Lifesciences a manufacturing base in Sri Lanka. The companies plan to invest over $20 million in phases and expect production to begin in 2028. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.